Werewolf Therapeutics, Inc. (HOWL)

NASDAQ: HOWL · IEX Real-Time Price · USD

6.02

-0.22 (-3.53%)

At close: May 1, 2024, 4:00 PM

6.33

+0.31 (5.15%)

After-hours: May 1, 2024, 6:14 PM EDT

Werewolf Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-37.37	-53.81	-201.93	-28.22	-18.23
Depreciation & Amortization	3.34	2.51	0.74	0.78	0.46
Share-Based Compensation	8.01	7.4	4.1	0.63	0.56
Other Operating Activities	-6.59	3.3	2.28	-4.99	-0.32
Operating Cash Flow	-32.61	-40.6	-42.88	-18.62	-9.54
Capital Expenditures	-0.77	-3.61	-0.5	-0.56	-0.27
Investing Cash Flow	-0.77	-3.61	-0.5	-0.56	-0.27
Share Issuance / Repurchase	18.43	15.99	109.43	-0.16	-0.19
Debt Issued / Paid	40	-0.09	0	0	0
Other Financing Activities	-	-	-	94.02	22.1
Financing Cash Flow	58.43	15.91	109.43	93.86	21.91
Net Cash Flow	25.05	-28.3	66.05	74.67	12.1
Free Cash Flow	-33.38	-44.21	-43.37	-19.18	-9.81
Free Cash Flow Margin	-167.38%	-269.54%	-	-	-
Free Cash Flow Per Share	-0.94	-1.53	-2.35	-19.09	-15.33

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).